Left Ventricular Assist Device Outflow Graft Obstruction: A Case Series.


Journal

ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 20 8 2019
medline: 12 1 2021
entrez: 20 8 2019
Statut: ppublish

Résumé

Dysfunction of different components within continuous-flow (CF) left ventricular assist device (LVAD) systems may cause adverse cardiovascular and end-organ sequelae. Outflow graft obstruction is a recognized type of LVAD component dysfunction. Ten patients were admitted and treated for LVAD outflow graft obstruction. Two of these patients subsequently developed recurrent outflow graft obstruction requiring reintervention; however, each reoccurrence was at a different site than the original obstruction. Thus, a total of 12 cases of obstruction were analyzed. The most common reasons for hospital admission were low flow LVAD alarms or decompensated heart failure. Presentation with outflow graft obstruction occurred an average of 3.0 years after LVAD implantation. Patients underwent echocardiographic evaluation at the time of admission. Left ventricular assist device component dysfunction was suspected based on echocardiographic findings, and follow-up contrast studies were used to establish the specific diagnosis of outflow graft stenosis. The majority of stenotic lesions (10/12) were treated percutaneously with balloon angioplasty and stenting with balloon-expandable endovascular prostheses. Postintervention, all patients had significant improvement in LVAD flow rates.

Identifiants

pubmed: 31425271
doi: 10.1097/MAT.0000000000001060
pii: 00002480-202006000-00013
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

657-662

Références

Scandroglio AM, Kaufmann F, Pieri M, et al. Diagnosis and treatment algorithm for blood flow obstructions in patients with left ventricular assist device. J Am Coll Cardiol 2016.67: 2758–2768.
Bhamidipati CM, Pal JD, Jones TK, et al. Outflow graft obstruction treated with transcatheter management: A novel therapy for a new diagnosis. Ann Thorac Surg 2017.103: e101–e104.
Hubbert L, Forssell C, Baranowski J, Lindgren B, Holm J, Ahn H. Endovascular stenting of a LVAD outflow graft thrombosis. ASAIO J 2017.63: e3–e5.
Pham DT, Kapur NK, Dermody M, Halin N. Stenting of an outflow graft obstruction after implantation of a continuous-flow, axial-flow left ventricular assist device. J Thorac Cardiovasc Surg 2015.150: e11–e12.
Pieri M, Scandroglio AM, Kukucka M, et al. Heart failure after 5 years on LVAD: Diagnosis and treatment of outflow graft obstruction. ASAIO J 2017.63: e1–e2.
Retzer EM, Tannenbaum SA, Fedson SE, et al. Successful percutaneous trans-catheter treatment of left ventricular assist device outflow graft stenosis with a covered stent. ESC Heart Fail 2015.2: 100–102.
Aliseda A, Chivukula VK, Mcgah P, et al. LVAD outflow graft angle and thrombosis risk. ASAIO J 2017.63: 14–23.
Barac YD, Nevo A, Schroder JN, Milano CA, Daneshmand MA. LVAD outflow graft role in pump thrombosis. ASAIO J, 2018. [Epub ahead of print]
Grinstein J, Kruse E, Collins K, et al. Screening for outflow cannula malfunction of Left Ventricular Assist Devices (LVADs) with the use of Doppler echocardiography: New LVAD-specific reference values for contemporary devices. J Card Fail 2016.22: 808–14.
Muller Moran HR, Kass M, Ravandi A, et al. Diagnosis of left ventricular assist device outflow graft obstruction using intravascular ultrasound. Circ Heart Fail 2016.9.
Rajagopal K, Salas de Armas IA, Jumean MF, Gregoric ID. Surgical treatment of late left ventricular assist device outflow obstruction due to extrinsic compression. J Heart Lung Transplant 2019.38: 472–474.
Alnabelsi T, Shafii AE, Gurley JC, Dulnuan K, Harris DD 2nd, Guglin M. Left ventricular assist device outflow graft obstruction: A complication specific to polytetrafluoroethylene covering. A word of caution! ASAIO J 2018.65:e58–e62..

Auteurs

Sriram Nathan (S)

From the Department of Cardiopulmonary Therapies and Transplantation, Center for Advanced Heart Failure, University of Texas Health Science Center at Houston/Memorial Hermann Hospital - Texas Medical Center, Houston, Texas.

Amaninderapal S Ghotra (AS)

Department of Internal Medicine, Division of Cardiovascular Medicine, University of Texas Health Science Center at Houston/Memorial Hermann Hospital - Texas Medical Center, Houston, Texas.

Keshava Rajagopal (K)

From the Department of Cardiopulmonary Therapies and Transplantation, Center for Advanced Heart Failure, University of Texas Health Science Center at Houston/Memorial Hermann Hospital - Texas Medical Center, Houston, Texas.

Chandni Patel (C)

From the Department of Cardiopulmonary Therapies and Transplantation, Center for Advanced Heart Failure, University of Texas Health Science Center at Houston/Memorial Hermann Hospital - Texas Medical Center, Houston, Texas.

Sachin Kumar (S)

From the Department of Cardiopulmonary Therapies and Transplantation, Center for Advanced Heart Failure, University of Texas Health Science Center at Houston/Memorial Hermann Hospital - Texas Medical Center, Houston, Texas.

Manish Patel (M)

From the Department of Cardiopulmonary Therapies and Transplantation, Center for Advanced Heart Failure, University of Texas Health Science Center at Houston/Memorial Hermann Hospital - Texas Medical Center, Houston, Texas.

Ismael Salas de Armas (I)

From the Department of Cardiopulmonary Therapies and Transplantation, Center for Advanced Heart Failure, University of Texas Health Science Center at Houston/Memorial Hermann Hospital - Texas Medical Center, Houston, Texas.

Marwan Jumean (M)

From the Department of Cardiopulmonary Therapies and Transplantation, Center for Advanced Heart Failure, University of Texas Health Science Center at Houston/Memorial Hermann Hospital - Texas Medical Center, Houston, Texas.

M Hakan Akay (MH)

From the Department of Cardiopulmonary Therapies and Transplantation, Center for Advanced Heart Failure, University of Texas Health Science Center at Houston/Memorial Hermann Hospital - Texas Medical Center, Houston, Texas.

Bindu Akkanti (B)

From the Department of Cardiopulmonary Therapies and Transplantation, Center for Advanced Heart Failure, University of Texas Health Science Center at Houston/Memorial Hermann Hospital - Texas Medical Center, Houston, Texas.

Biswajit Kar (B)

From the Department of Cardiopulmonary Therapies and Transplantation, Center for Advanced Heart Failure, University of Texas Health Science Center at Houston/Memorial Hermann Hospital - Texas Medical Center, Houston, Texas.

Igor D Gregoric (ID)

From the Department of Cardiopulmonary Therapies and Transplantation, Center for Advanced Heart Failure, University of Texas Health Science Center at Houston/Memorial Hermann Hospital - Texas Medical Center, Houston, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH